tiprankstipranks
Allergy Therapeutics Appoints New Financial Adviser
Company Announcements

Allergy Therapeutics Appoints New Financial Adviser

Allergy Therapeutics (GB:AGY) has released an update.

Don't Miss Our Christmas Offers:

Allergy Therapeutics, a UK-based commercial biotechnology company specializing in allergy vaccines, has announced the appointment of Cavendish Capital Markets Limited as their new Nominated Adviser and Corporate Broker. This partnership is set to enhance the company’s financial and strategic advisory services, with Cavendish bringing in-depth knowledge of capital markets. The firm’s focus on allergy vaccine development and commercialization continues with a product line that includes treatments for a variety of allergens.

For further insights into GB:AGY stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskAllergy Therapeutics Rectifies Share Option Oversight
TipRanks UK Auto-Generated NewsdeskAllergy Therapeutics Shows Promising Results for Peanut Allergy
TipRanks UK Auto-Generated NewsdeskAllergy Therapeutics Begins Innovative Paediatric Allergy Trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App